Expand ACON Menu
ACON MENU

ACON Latest Press Releases

-- April 22, 2026 --

Aclarion Announces $2.5 Million Stock Repurchase Plan Globe Newswire 8:30 AM

-- April 16, 2026 --

Aclarion Secures U.S. Patent Advancing Scalable, AI-Driven Assessment of Chronic Low Back Pain Globe Newswire 6:47 AM

-- April 14, 2026 --

Aclarion Receives Pinnacle Award for AI Innovation Globe Newswire 8:00 AM

-- April 8, 2026 --

Aclarion Announces Agreement with Weill Cornell Medicine Globe Newswire 8:00 AM

-- April 7, 2026 --

Aclarion Highlights Growing Adoption of Nociscan at The London Clinic with New Physician Video Globe Newswire 8:00 AM

-- March 24, 2026 --

Echo Lake Capital Calls for the Resignation of David Neal From the Board of Directors of Aclarion Inc. ACCESS Newswire 8:00 AM

-- March 19, 2026 --

Aclarion, Inc. Adopts Limited Duration Stockholder Rights Plan Globe Newswire 9:25 AM
Aclarion Publishes CEO Shareholder Letter Highlighting Strategic Progress and 2026 Catalysts Globe Newswire 6:00 AM

-- March 17, 2026 --

Aclarion to Participate in the 38th Annual ROTH Conference, Highlighting Key 2026 Catalysts and Strong Balance Sheet Globe Newswire 6:00 AM

-- March 12, 2026 --

Aclarion CEO Brent Ness to Attend LSI USA 2026 Globe Newswire 6:00 AM

-- February 5, 2026 --

Aclarion Publishes 2026 Shareholder Letter from the Chairman Globe Newswire 6:00 AM

-- February 3, 2026 --

Aclarion Adds High-Volume Practice, Source Healthcare, to Support Nociscan Growth and Real-World Evidence Generation Globe Newswire 6:00 AM

-- January 13, 2026 --

Aclarion Strengthens Balance Sheet and Extends Cash Runway Into 2028 Globe Newswire 6:00 AM

-- January 8, 2026 --

Morning Market Pulse: From Orbit to Biomaterials, Innovation Drives the Tape Globe Newswire 9:32 AM
Aclarion Provides 2025 Update and 2026 Corporate Outlook Globe Newswire 6:00 AM

-- January 6, 2026 --

Aclarion Announces First Patient Enrollments at Two Additional CLARITY Trial Sites and Provides Guidance on Expected Availability of Initial Data Globe Newswire 6:00 AM

-- December 4, 2025 --

Aclarion Announces Publication of Nociscan Article in Special Pain Issue of the International Journal of Spine Surgery (IJSS) Globe Newswire 8:00 AM

-- December 2, 2025 --

Aclarion Appoints Jason Brosniak as Commercial Director to Drive Adoption and Market Expansion in the Eastern U.S. Globe Newswire 8:00 AM
Market Data Delayed 15 Minutes